IAA
UTHR icon

Independent Advisor Alliance’s United Therapeutics UTHR Stock Holding History

Independent Advisor Alliance’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
856
+22
+3% +$12.4K 0.01% 692
2026
Q1 		$495K Buy
834
+1
+0.1% +$498 0.01% 1112
2025
Q4 		$406K Buy
833
+27
+3% +$12.6K 0.01% 711
2025
Q3 		$338K Buy
806
+8
+1% +$2.69K 0.01% 735
2025
Q2 		$229K Buy
+798
New +$238K 0.01% 792

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Independent Advisor Alliance's UTHR Position: Q2 2026 in Review

Independent Advisor Alliance increased its United Therapeutics (UTHR) stake by 2.6% in Q2 2026, buying an estimated $12.4K and bringing the position to 856 shares worth $464K. The position accounts for 0.01% of the portfolio, ranked #692.

Independent Advisor Alliance first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $495K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Independent Advisor Alliance held 856 shares of United Therapeutics worth $464K as of Q2 2026.
  • Independent Advisor Alliance bought 22 United Therapeutics shares in Q2 2026, an estimated $12.4K.
  • United Therapeutics made up 0.01% of Independent Advisor Alliance's portfolio in Q2 2026, its #692 holding.
  • Independent Advisor Alliance first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Independent Advisor Alliance's United Therapeutics position peaked at $495K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.